Bioactivity and Drug Delivering Ability of a Chitosan/46S6 Melted Bioactive Glass Biocomposite Scaffold

580 Words2 Pages

The morphology of the prepared scaffolds is presented in Fig. 2. It can be observed that all the prepared scaffolds have wide range of interconnected pores including macro, micro and nanopores, as was also confirmed by a mercury porosimeter. By increasing the MB concentration, the pore size in the scaffolds also increased. The average pore size of the scaffolds fabricated was increased from 150 ± 5 µm to 170 ± 24 µm by increasing the concentration of MB from 0 mass-% to 66.5 mass-%. The wide range of pores sizes for all the scaffolds fabricated with different MB concentration indicated that pores in all the scaffolds were interconnected and seeded cells would be proliferated throughout the 3D structure of the scaffold. Thepore size was found to be in the range of 100–200 µm, suitable for tissue engineering applications [18]. Pores are essential for the migration and proliferation of the cells, nutrient supply and vascularization [19]. The surface of the chitosan control scaffold was found to be smooth compared to the Ch/MB composite scaffold. This may be due to the incorporation of MB that significantly increases the surface area of the scaffolds, further enhancing the bioactivity of the scaffolds [20, 21]. The porosity percentage for the prepared scaffolds was determined by MIP and liquid displacement methods, and there was no

significant difference between the two methods, as demonstrated in Table 1.

3.2 Mechanical properties

The mechanical behaviour of the prepared scaffolds was characterized by determining the fracture toughness K. Ch alone exhibits low fracture toughness, as shown in Fig. 3. In the Ch/MB scaffolds a marked change could be observed: as the amount of glass increased the fracture toughness increased. Table ...

... middle of paper ...

...nal gelatin/montmorillonite-chitosan scaffolds for tissue engineering. React. Funct. Polymer. 67 (2007) 780–788

[27] Mansur, H., Costa, H.: Nanostructured poly(vinyl alcohol)/bioactive glass and poly (vinylalcohol)/chitosan/bioactive glass hybrid scaffolds for biomedical applications. Chem. Eng. J. 137 (2008) 72–83

[28] Petrova, S., Miloshev, S., Mateva, R., Illev, I.: Synthesis of amphiphilic PEG–PCL–PEG triblock copolymer. J. Univ. Chem. Technol. Metall. 43 (2008) 199–204

[29] Li, J., Dou, Y., Yang, J., Yin, Y., Zhang, H., Yao, F., Wang, H., Yao, Y.: Surface characterization and biocompatibility of micro- and nano-hydroxyapatite/chitosan–gelatin network films. Mater. Sci. Eng. C29 (2009) 1207–1215

[30] Chai, C., Nissan, B.B., Pyke, S., Evans, L.: Sol-gel derived hydroxylapatite coatings for biomedical applications. Mater. and Manufact. Proc. 10 (1995) 205–216

More about Bioactivity and Drug Delivering Ability of a Chitosan/46S6 Melted Bioactive Glass Biocomposite Scaffold

Open Document